Approach | Scaffold biomaterial | Load | Administration | Target/tumor model |
---|---|---|---|---|
Two step | Ethylene-vinyl-acetate (EVA) polymers rods | 1st CCL19 2nd Tumor lysate | Coimplantation | E.G7-OVA tumor cells injected mice [61] |
Hydrogel - Thermosensitive monomethoxypoly(ethylene glycol)-co-poly(lactic-co-glycolic acid) copolymer (mPEG-PLGA) | 1st - GM-CSF 2nd - Tumor antigens | 2 injections (injection of viral or nonviral vectors in a 2nd step) | Murine melanoma model [62] | |
One step | Poly(lactide-co-glycolide) | GM-CSF, CpG, autologous tumor lysate | Implantation | Human melanoma Phase I clinical trial NCT01753089 |
Poly(lactide-co-glycolide) | GM-CSF, CpG, tumor lysate | Implantation | ||
Poly(lactide-co-glycolide) | GM-CSF, CpG, tumor lysate | Implantation | Murine Lewis lung carcinoma (LLC) [64] | |
Poly(lactide-co-glycolide) | GM-CSF, CpG, tumor lysate | Implantation | ||
Poly(lactide-co-glycolide) | GM-CSF, CpG, Tumor lysate | Implantation | Murine melanoma model; combination with anti PD-1 or CTLA-4 mAb [69] | |
Poly(lactide-co-glycolide) | CCL20, CpG, tumor lysate | Implantation | Murine melanoma model [66] | |
Poly(lactide-co-glycolide) | Flt3L, CpG, tumor lysate | Implantation | Murine melanoma model [66] | |
Poly(lactide-co-glycolide) | GM-CSF, MPLA, tumor lysate | Implantation | Murine melanoma model [64] | |
Poly(lactide-co-glycolide) | GM-CSF, Poly-I:C, Tumor lysate | Implantation | Murine melanoma model [64] | |
Poly(lactide-co-glycolide) | GM-CSF, Poly-I:C, tumor lysate | Implantation | Murine Lewis lung carcinoma (LLC) [64] | |
Hydrogel/cryogel–alginate polymer | GM-CSF, CpG, irradiated tumor cells | Injection | Murine breast cancer [70] | |
Hydrogel/cryogel–alginate polymer | GM-CSF, CpG, irradiated tumor cells | Injection | Murine melanoma model [71] | |
Covalent and ionic crosslinked cryogel–alginate polymer | GM-CSF, CpG, irradiated -tumor cells | Injection | Murine breast cancer [72] | |
Crosslinking hydrogel- dextran vinylsulfone and tetra-thiolated polyethyleneglycol | CCL20 + PLGA microparticles encapsulating IL-10, siRNA and DNA antigen | Injection | Murine A20 B cell lymphoma [73] | |
Mesoporous silica rods (MSRs) - synthetic amorphous silica | GM-CSF, CpG, OVA | Injection | Prophylactic action in a murine model, injected with EG7-OVA lymphoma cells [74] |